$330 Million is the total value of SILVERARC CAPITAL MANAGEMENT, LLC's 80 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRTX | Mirati Therapeutics Inccall | $6,534,000 | +20.6% | 150,000 | 0.0% | 1.98% | +18.2% | |
| BMRN | BioMarin Pharmaceutical Incequities | $884,800 | +2.1% | 10,000 | 0.0% | 0.27% | 0.0% | |
| PNT | Point Biopharma Global Incequities | $624,979 | -26.4% | 93,700 | 0.0% | 0.19% | -28.1% | |
| ALGS | Aligos Therapeutics Incequities | $472,020 | -23.1% | 631,887 | 0.0% | 0.14% | -24.7% | |
| SNDX | Syndax Pharmaceuticals Incequities | $290,400 | -30.6% | 20,000 | 0.0% | 0.09% | -31.8% | |
| Eloxx Pharmaceuticals Incequities | $260,101 | +23.7% | 54,075 | 0.0% | 0.08% | +21.5% | ||
| Rocket Pharmaceuticals Inc Wtswarrants | $17,821 | -10.5% | 104,828 | 0.0% | 0.01% | -16.7% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- SILVERARC CAPITAL, LLC #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTRA-CELLULAR THERAPIES INC | 12 | Q3 2023 | 7.8% |
| IMMUNOGEN INC | 12 | Q3 2023 | 8.3% |
| Morphic Holding Inc | 12 | Q3 2023 | 4.5% |
| UNUM THERAPEUTICS INC | 12 | Q3 2023 | 3.2% |
| INSMED INC | 12 | Q3 2023 | 3.5% |
| UNITED THERAPEUTICS CORP DEL | 12 | Q3 2023 | 2.2% |
| MERUS N V | 11 | Q3 2023 | 5.1% |
| VERACYTE INC | 11 | Q3 2023 | 4.9% |
| EVOGENE LTD | 11 | Q3 2023 | 1.6% |
| COMPUGEN LTD | 11 | Q3 2023 | 1.1% |
View SILVERARC CAPITAL MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Benitec Biopharma Inc.Sold out | February 08, 2023 | 0 | 0.0% |
| DELCATH SYSTEMS, INC.Sold out | February 08, 2022 | 0 | 0.0% |
View SILVERARC CAPITAL MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G/A | 2023-02-08 |
| 13F-HR | 2022-10-28 |
View SILVERARC CAPITAL MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.